Demelo-Rodriguez P. Galeano-Valle F. Salzano A. et al.

Pulmonary embolism: a practical guide for the busy clinician.

Heart Failure Clin. 16: 317-330Konstantinides S.v. Meyer G. Becattini C. et al.

2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).

Eur Heart J. 41: 543-603Boon G.J.A.M. Huisman M.v. Klok F.A.

Determinants and management of the post–pulmonary embolism syndrome.

Semin Respir Crit Care Med. 42: 299-307Klok F.A. van der Hulle T. den Exter P.L. et al.

The post-PE syndrome: a new concept for chronic complications of pulmonary embolism.

Blood Rev. 28: 221-226Hoeper M.M. Bogaard H.J. Condliffe R. et al.

Definitions and diagnosis of pulmonary hypertension.

J Am Coll Cardiol. 62: D42-D50Galiè N. Humbert M. Vachiery J.-L. et al.

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Eur Heart J. 37: 67-119Simonneau G. Galiè N. Rubin L.J. et al.

Clinical classification of pulmonary hypertension.

J Am Coll Cardiol. 43: S5-S12Humbert M. Morrell N.W. Archer S.L. et al.

Cellular and molecular pathobiology of pulmonary arterial hypertension.

J Am Coll Cardiol. 43: S13-S24Ezedunukwe I.R. Enuh H. Nfonoyim J. et al.

Anticoagulation therapy versus placebo for pulmonary hypertension.

Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD010695.pub2Johnson S.R. Granton J.T. Mehta S.

Thrombotic arteriopathy and anticoagulation in pulmonary hypertension.

Chest. 130: 545-552Delcroix M. Torbicki A. Gopalan D. et al.

ERS statement on chronic thromboembolic pulmonary hypertension.

Eur Respir J. 57: 2002828Dorfmüller P. Günther S. Ghigna M.-R. et al.

Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature.

Eur Respir J. 44: 1275-1288Pepke-Zaba J. Delcroix M. Lang I. et al.

Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.

Circulation. 124: 1973-1981Klok F.A. Dzikowska-Diduch O. Kostrubiec M. et al.

Derivation of a clinical prediction score for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

J Thromb Haemost. 14: 121-128Klok F.A. Tesche C. Rappold L. et al.

External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.

Thromb Res. 135: 796-801Kim N.H. Delcroix M. Jais X. et al.

Chronic thromboembolic pulmonary hypertension.

Eur Respir J. 53: 1801915Claeys M. Claessen G. la Gerche A. et al.

Impaired cardiac reserve and abnormal vascular load limit exercise capacity in chronic thromboembolic disease.

JACC: Cardiovasc Imaging. 12: 1444-1456Klok F.A. Ageno W. Ay C. et al.

Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary Circulation and Right Ventricular Function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the European Respiratory Society.

Eur Heart J. 43: 183-189Fukuda K. Date H. Doi S. et al.

Guidelines for the treatment of pulmonary hypertension (JCS 2017/JPCPHS 2017).

Circ J. 83: 842-945Rosenkranz S. Howard L.S. Gomberg-Maitland M. et al.

Systemic consequences of pulmonary hypertension and right-sided heart failure.

Circulation. 141: 678-693Yaghi S. Novikov A. Trandafirescu T.

Clinical update on pulmonary hypertension.

J Investig Med. 68: 821-827Papamatheakis D.G. Poch D.S. Fernandes T.M. et al.

Chronic Thromboembolic Pulmonary Hypertension.

J Am Coll Cardiol. 76: 2155-2169Chang K.Y. Duval S. Badesch D.B. et al.

Mortality in pulmonary arterial hypertension in the modern era: early insights from the pulmonary hypertension association registry.

J Am Heart Assoc. 11Humbert M. Sitbon O. Chaouat A. et al.

Pulmonary arterial hypertension in france.

Am J Respir Crit Care Med. 173: 1023-1030Ling Y. Johnson M.K. Kiely D.G. et al.

Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension.

Am J Respir Crit Care Med. 186: 790-796Frost A.E. Badesch D.B. Miller D.P. et al.

Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension.

Chest. 144: 1521-1529Kerr K.M. Elliott C.G. Chin K. et al.

Results from the United States chronic thromboembolic pulmonary hypertension registry.

Chest. 160: 1822-1831Kolte D. Lakshmanan S. Jankowich M.D. et al.

Mild pulmonary hypertension is associated with increased mortality: a systematic review and meta-analysis.

J Am Heart Assoc. 7https://doi.org/10.1161/JAHA.118.009729Brinza C. Covic A. Stefan A.E. et al.

Pulmonary arterial hypertension and adverse outcomes after kidney transplantation: a systematic review and meta-analysis.

J Clin Med. 11: 1944Xiong A. Liu Q. Zhong J. et al.

Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis.

Adv Rheumatol. 62: 10Bertoletti L. Mismetti V. Giannakoulas G.

Use of anticoagulants in patients with pulmonary hypertension.

Hämostaseologie. 40: 348-355Rich S. Kaufmann E. Levy P.S.

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

N Engl J Med. 327: 76-81Khan M.S. Usman M.S. Siddiqi T.J. et al.

Is Anticoagulation Beneficial in Pulmonary Arterial Hypertension?.

Circ Cardiovasc Qual Outcomes. 11https://doi.org/10.1161/CIRCOUTCOMES.118.004757Jose A. Eckman M.H. Elwing J.M.

Anticoagulation in pulmonary arterial hypertension: a decision analysis.

Pulm Circ. 9: 1-12

Off-label use for direct oral anticoagulants: valvular atrial fibrillation, heart failure, left ventricular thrombus, superficial vein thrombosis, pulmonary hypertension—a systematic review.

Ann Pharmacother. 55: 995-1009Burmeister C. Ghazaleh S. Patel N. et al.

Direct Oral Anticoagulants Versus Vitamin K Antagonists for The Treatment of Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-Analysis.

J Am Coll Cardiol. 79: 1655Sedhom R. Megaly M. Gupta E. et al.

Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review.

J Thromb Thrombolysis. 53: 51-57Salzano A. Demelo-Rodriguez P. Marra A.M.A.M. et al.

A focused review of gender differences in antithrombotic therapy.

Curr Med Chem. 24: 2576-2588Stevens S.M. Woller S.C. Baumann Kreuziger L. et al.

Executive summary: antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report.

Chest. 160: 2247-2259Hindricks G. Potpara T. Dagres N. et al.

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Eur Heart J. 42: 373-498Corsini A. Ferri N. Proietti M. et al.

Edoxaban and the issue of drug-drug interactions: from pharmacology to clinical practice.

Drugs. 80: 1065-1083Olsson K.M. Delcroix M. Ghofrani H.A. et al.

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

Circulation. 129: 57-65Fuster V. Steele P.M. Edwards W.D. et al.

Primary pulmonary hypertension: natural history and the importance of thrombosis.

Circulation. 70: 580-587McLaughlin V.v. Archer S.L. Badesch D.B. et al.

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension.

J Am Coll Cardiol. 53: 1573-1619Barberà J.A. Román A. Gómez-Sánchez M.Á. et al.

Guidelines on the diagnosis and treatment of pulmonary hypertension: summary of recommendations.

Archivos de Bronconeumologia. 54: 205-215Gabriel L. Delavenne X. Bedouch P. et al.

Risk of direct oral anticoagulant bioaccumulation in patients with pulmonary hypertension.

Respiration. 91: 307-315Margelidon-Cozzolino V. Delavenne X. Catella-Chatron J. et al.

Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs?.

Blood Rev. 37: 100579Bunclark K. Newnham M. Chiu Y. et al.

A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension.

J Thromb Haemost. 18: 114-122Sena S. Bulent M. Derya K. et al.

Real-life data of direct anticoagulant use, bleeding risk and venous thromboembolism recurrence in chronic thromboembolic pulmonary hypertension patients: an observational retrospective study.

Pulm Circ. 10: 1-10Hayashi H. Tsuji A. Ueda J. et al.

Comparison of efficacy and safety between direct oral anticoagulant and warfarin in patients with chronic thromboembolic pulmonary hypertension.

Circulation. 138: A15733Porres-Aguilar M. Hoeper M.M. Rivera-Lebron B.N. et al.

Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension.

J Thromb Thrombolysis. 52: 791-796Klinger J.R. Elliott C.G. Levine D.J. et al.

Therapy for pulmonary arterial hypertension in adults: update of the chest guideline and expert panel report.

Chest. 155: 565-586Rivera-Caravaca J.M. Roldán V. Esteve-Pastor M.A. et al.

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients.

Thromb Haemost. 117Romiti G.F. Pastori D. Rivera-Caravaca J.M. et al.

Adherence to the “atrial fibrillation better care” pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients.

Thromb Haemost. 122: 406-414Lip G.Y.H. Lane D.A. Lenarczyk R. et al.

Integrated care for optimizing the management of stroke and associated heart disease: a position paper of the European Society of Cardiology Council on Stroke.

Eur Heart J. 43: 2442-2460